Intra-host dengue virus genetic diversity among primary and secondary infections in Laos

Grant number: 222119/Z/20/Z

Grant search

Key facts

  • Disease

    Dengue
  • Start & end year

    2021
    2023
  • Known Financial Commitments (USD)

    $166,748.28
  • Funder

    Wellcome Trust
  • Principal Investigator

    Dr. Vilayouth Phimolsannusith
  • Research Location

    Lao People's Democratic Republic
  • Lead Research Institution

    University of Oxford
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

There are an estimated 100-400 million cases of dengue worldwide per year with the highest burden of disease in Asia. The virus (DENV) is a positive-sense single stranded RNA virus belonging to the genus Flavivirus. There are four serotypes: DENV1 to DENV4. Dengue virus RNA dependent RNA polymerase has no proof-reading activity, resulting in accumulation of mutations at each replication cycle. Therefore, within an infected individual, there is diversification of the DENV genome sequence leading to the presence of intra- host genetic variants (quasispecies), which may then lead, under selective pressure, to the emergence of a new strain of higher virulence. Previous findings suggested that immune pressure drives intra-host diversity. My research will explore whether serotype-specific past immunity influences intra-host DENV genetic diversity during acute infection. Objectives: - To describe intra host DENV genetic diversity in patients with primary and secondary infections - To compare quasispecies profiles between primary and secondary infections - To compare quasispecies profiles in secondary infections between two patient groups previously exposed to a different serotype. Impact : We expect the findings of this project would permit a better understanding of processes leading to viral genetic variation, and could eventually be useful for improving viral surveillance systems and epidemic forecasting.